Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00081523 · ClinicalTrials.gov registry record

Natural History of Sickle Cell Disease

A clinical trial of Pain Crisis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Recruiting
Registry status
3,500
Enrollment target
3
Study locations

NCT00081523 is a study of Pain Crisis that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 3,500 participants. The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00081523, a study of Pain Crisis, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

RECRUITING
Registry status
3,500 participants
Enrollment target
3
Study locations

Study Summary

This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center....

Conditions Studied

Study Locations (3)

Maryland

  • Suburban Hospital - Bethesda
  • National Institutes of Health Clinical Center - Bethesda

District of Columbia

  • Childrens National Health Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2004-04-29

What the Registry Record Tells You About NCT00081523

The ClinicalTrials.gov registry entry for NCT00081523 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain Crisis appearing as the primary indexed condition, and to 0 interventions.

NCT00081523 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00081523 about?

NCT00081523 is a clinical study titled "Natural History of Sickle Cell Disease". This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our cli...

What is the current status of trial NCT00081523?

This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2004-04-29.

What conditions does trial NCT00081523 study?

This clinical trial studies the following conditions: Pain Crisis.

Who is sponsoring clinical trial NCT00081523?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00081523 being conducted?

This trial has 3 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.